Table 5 Cytotoxic activity of novel azepine derivatives against cancer and normal cell lines.
Compounds | In-vitro Cytotoxicity IC50 (μM)* | |||
---|---|---|---|---|
WI38 | HCT-116 | HepG-2 | MCF-7 | |
Anticancer GANT-61 (HH) reference inhibitor | 55.03 ± 3.1 | 10.19 ± 0.3 | 21.90 ± 0.2 | 14.67 ± 0.2 |
Diazepine (3a) | 168.08 ± 3.5 | 14.25 ± 1.1 | 24.57 ± 1.8 | 19.21 ± 0.8 |
Oxazepine (4a) | 172.04 ± 3.7 | 16.95 ± 2.4 | 34.23 ± 2.0 | 28.28 ± 1.4 |